SCHEMBL11344823

SCHEMBL11344823

Cc1cc(C(=O)Nc2c(O)ccc3c(S(=O)(=O)O)cccc23)ccc1NC(=O)Nc1ccc(C(=O)Nc2c(O)ccc3c(S(=O)(=O)O)cccc23)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 5/20 0.46
TIMP3 P35625 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
MAPT P10636 3/20 0.45
USP2 O75604 2/20 0.45
RECQL P46063 2/20 0.45
HSD17B10 Q99714 2/20 0.45
P2RY11 Q96G91 2/20 0.45
ENPP3 O14638 1/20 0.45
ENTPD3 O75355 1/20 0.45
NR1I2 O75469 1/20 0.45
PRKD3 O94806 1/20 0.45
TDP2 O95551 1/20 0.45
CBX7 O95931 1/20 0.45
NSD2 O96028 1/20 0.45
ESR1 P03372 1/20 0.45
PRKCG P05129 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907596 0.94 HPSE (0.42) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11345247 0.89 HPSE (0.43) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11345458 0.87 HPSE (0.48) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11344939 0.87 HPSE (0.49) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11439440 0.86 TTR (0.43) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11348931 0.85 HPSE (0.45) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11338811 0.85 HPSE (0.49) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11341085 0.84 HPSE (0.43) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11348611 0.84 RECQL (0.52) HPSETIMP3MEN1KMT2ATDP1
SCHEMBL11433769 0.84 TTR (0.43) HPSETIMP3MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed